Reuters logo
a month ago
BRIEF-Geneuro announces first patient treated in phase 2A study with GNBAC1 in type 1 diabetes
June 19, 2017 / 5:40 AM / a month ago

BRIEF-Geneuro announces first patient treated in phase 2A study with GNBAC1 in type 1 diabetes

1 Min Read

June 19 (Reuters) - GENEURO SA:

* ANNOUNCES FIRST PATIENT TREATED IN PHASE 2A STUDY WITH GNBAC1 IN TYPE 1 DIABETES

* AUSTRALIAN PHASE 2A CLINICAL STUDY PLANS TO ENROLL 60 ADULT PATIENTS IN OVER 10 CENTERS

* LAST PATIENT ENROLMENT IS EXPECTED BY END 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below